Aumolertinib Combined with Carbamazepine and Intrathecal Pemetrexed for EGFR-mutated LM NSCLC with Symptomatic Epilepsy

被引：0
|
作者：
Li, L. [1 ]
Yang, M. [2 ]
Huang, D. Y. [1 ]
Liu, F. [2 ]
Zhang, L. [3 ]
Song, X. W. [1 ]
Lv, Y. J. [1 ]
Teng, C. [1 ]
Fan, C. J. [1 ]
Tian, D. [1 ]
Shen, W. X. [1 ]
Jiang, Q. Y. [1 ]
Lu, D. [1 ]
Xin, T. [1 ]
机构：
[1] Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China
[2] China Japan Friendship Hosp, Beijing, Peoples R China
[3] Daqing Oilfield Gen Hosp, Daqing, Heilongjiang, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Aumolertinib; Intrathecal; injection; Symptomatic epilepsy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.09-42
引用
收藏
页码：S351 / S351
页数：1
相关论文
共 50 条
  • [31] Efficacy of dacomitinib in patients with EGFR-mutated NSCLC and brain metastases
    Zhang, Jinyao
    Wang, Yan
    Liu, Ziling
    Wang, Lin
    Yao, Yu
    Liu, Yutao
    Hao, Xue Zhi
    Wang, Jianyang
    Xing, Puyuan
    Li, Junling
    THORACIC CANCER, 2021, 12 (24) : 3407 - 3415
  • [32] Chemotherapy in EGFR-mutated NSCLC: optimizing combinations with TKIs and amivantamab
    Rafael Rosell
    María González-Cao
    Nature Reviews Clinical Oncology, 2024, 21 : 169 - 170
  • [33] Clinical analysis of the presence of comutations in patients with EGFR-mutated NSCLC
    Rubio, Jaime
    Santolaya, Carlota
    Fernandez, Marina
    Villalba, Paula Lucia
    Avedillo, Mercedes
    Garcia-Foncillas, Jesus
    Domine, Manuel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC
    Lu, Shun
    Kato, Terufumi
    Dong, Xiaorong
    Ahn, Myung-Ju
    Le-Van Quang
    Soparattanapaisarn, Nopadol
    Inoue, Takako
    Wang, Chih-Liang
    Huang, Meijuan
    Yang, James Chih-Hsin
    Cobo, Manuel
    Ozguroglu, Mustafa
    Casarini, Ignacio
    Dang-Van Khiem
    Sriuranpong, Virote
    Cronemberger, Eduardo
    Takahashi, Toshiaki
    Runglodvatana, Yotsawaj
    Chen, Ming
    Huang, Xiangning
    Grainger, Ellie
    Ghiorghiu, Dana
    van der Gronde, Toon
    Ramalingam, Suresh S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (07): : 585 - 597
  • [35] Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC
    Banna, Giuseppe Luigi
    Addeo, Alfredo
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (16): : 1555 - 1556
  • [36] MET amplification increases the metastatic spread of EGFR-mutated NSCLC
    Baldacci, Simon
    Kherrouche, Zoulika
    Cockenpot, Vincent
    Stoven, Luc
    Copin, Marie Christine
    Werkmeister, Elisabeth
    Marchand, Nathalie
    Kyheng, Maeva
    Tulasne, David
    Cortot, Alexis B.
    LUNG CANCER, 2018, 125 : 57 - 67
  • [37] EGFR-Mutated NSCLC: Clinical Practice Assessment and Gap Analysis
    Herrmann, Tara
    Hamarstrom, Elaine
    Ramalingam, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1218 - S1219
  • [38] Osimertinib in combination with bevacizumab in EGFR-Mutated NSCLC with leptomeningeal metastases
    Jiang, Tao
    Xu, Xiaobo
    Chen, Xiaojuan
    Ding, Ning
    Hu, Qin
    Zhou, Caicun
    Hu, Jie
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (06) : 2514 - 2517
  • [39] Immune Checkpoint Inhibitors in EGFR-Mutated NSCLC: Dusk or Dawn?
    Qiao, Meng
    Jiang, Tao
    Liu, Xinyu
    Mao, Shiqi
    Zhou, Fei
    Li, Xuefei
    Zhao, Chao
    Chen, Xiaoxia
    Su, Chunxia
    Ren, Shengxiang
    Zhou, Caicun
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (08) : 1267 - 1288
  • [40] Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC
    Lu, Shun
    Kato, Terufumi
    Dong, Xiaorong
    Ahn, Myung-Ju
    Quang, Le-Van
    Soparattanapaisarn, Nopadol
    Inoue, Takako
    Wang, Chih-Liang
    Huang, Meijuan
    Yang, James Chih-Hsin
    Cobo, Manuel
    Ozguroglu, Mustafa
    Casarini, Ignacio
    Khiem, Dang-Van
    Sriuranpong, Virote
    Cronemberger, Eduardo
    Takahashi, Toshiaki
    Runglodvatana, Yotsawaj
    Chen, Ming
    Huang, Xiangning
    Grainger, Ellie
    Ghiorghiu, Dana
    van der Gronde, Toon
    Ramalingam, Suresh S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024,
12345